Beauty M&A and Leadership Shifts: Galderma, Douglas, Shiseido

· Beauty & Fashion · Switzerland · France

Three separate developments are reshaping the beauty industry's corporate landscape. Galderma agreed to acquire California-based ZO Skin Health for an enterprise value of USD 1.5 billion, strengthening its medical skincare portfolio. Douglas Group named Jean-Marc Bellaiche, former CEO of Printemps, as its new CEO effective November 1, 2026, succeeding Sander van der Laan who retires after four years leading the European beauty retailer. Meanwhile, Shiseido is suing Shein for more than EUR 2.6 million over sales of its beauty products outside authorized distribution channels, in a case that could test selective distribution agreements against global e-commerce platforms.

Why it matters：These moves signal consolidation in medical skincare, leadership turnover at a major European retailer, and a landmark legal test of brand distribution control against e-commerce giants.

Key points

  • Galderma is acquiring ZO Skin Health for USD 1.5 billion enterprise value.
  • Douglas appoints Jean-Marc Bellaiche as CEO from November 1, 2026.
  • Shiseido seeks over EUR 2.6 million from Shein over unauthorized distribution.

Sources (original reporting)

More stories from this day